LLY

858

+1.28%↑

UNH

565.37

+0.22%↑

NVO

131.55

+1.32%↑

JNJ

154.58

-0.46%↓

MRK

125.76

+1.19%↑

LLY

858

+1.28%↑

UNH

565.37

+0.22%↑

NVO

131.55

+1.32%↑

JNJ

154.58

-0.46%↓

MRK

125.76

+1.19%↑

LLY

858

+1.28%↑

UNH

565.37

+0.22%↑

NVO

131.55

+1.32%↑

JNJ

154.58

-0.46%↓

MRK

125.76

+1.19%↑

LLY

858

+1.28%↑

UNH

565.37

+0.22%↑

NVO

131.55

+1.32%↑

JNJ

154.58

-0.46%↓

MRK

125.76

+1.19%↑

LLY

858

+1.28%↑

UNH

565.37

+0.22%↑

NVO

131.55

+1.32%↑

JNJ

154.58

-0.46%↓

MRK

125.76

+1.19%↑

Search

AstraZeneca PLC ADR

Geschlossen

78.71 0.86

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

78.05

Max

78.75

Empfehlungen

By TipRanks

Empfehlungen

Starkes Kaufsignal

12-Monats-Prognose

+7.39 upside

Technischer Score

By Trading Central

Vertrauen

Strong Bullish Evidence

AstraZeneca PLC ADR Chart

Ähnliche Nachrichten

12. Juli 2024, 19:57 UTC

Wichtige Markttreiber

Instil Bio Shares Surge Following Rental Agreement with AstraZeneca

15. Juli 2024, 06:04 UTC

Akquisitionen, Fusionen, Übernahmen

AstraZeneca: Amolyt Pharma's Hldrs Eligible to Receive $250M On Achieving Specific Milestone

15. Juli 2024, 06:04 UTC

Akquisitionen, Fusionen, Übernahmen

AstraZeneca: Amolyt Pharma's Hldrs Eligible to Receive $250M On Achieving Specific Milestone

15. Juli 2024, 06:02 UTC

Akquisitionen, Fusionen, Übernahmen

AstraZeneca: Acquisition Includes $800M Upfront at Deal Closing

15. Juli 2024, 06:02 UTC

Akquisitionen, Fusionen, Übernahmen

AstraZeneca: Amolyt Pharma's Total Consideration of Up to $1.05B

15. Juli 2024, 06:01 UTC

Akquisitionen, Fusionen, Übernahmen

AstraZeneca: Acquisition Bolsters Alexion Rare Disease Late-Stage Pipeline

15. Juli 2024, 06:00 UTC

Akquisitionen, Fusionen, Übernahmen

AstraZeneca Completes Acquisition of Amolyt Pharma

15. Juli 2024, 06:00 UTC

Akquisitionen, Fusionen, Übernahmen

AstraZeneca PLC Acquisition of Amolyt Pharma completed

15. Juli 2024, 06:00 UTC

Akquisitionen, Fusionen, Übernahmen

AstraZeneca PLC Acquisition of Amolyt Pharma completed

20. Juni 2024, 20:16 UTC

Top News

Why Wall Street Is Chasing Ozempic Wannabes -- Heard on the Street -- Update

20. Juni 2024, 18:09 UTC

Top News

Why Wall Street Is Chasing Ozempic Wannabes -- Heard on the Street -- Update

20. Juni 2024, 11:00 UTC

Top News

Why Wall Street Is Chasing Ozempic Wannabes -- Heard on the Street -- WSJ

10. Juni 2024, 06:14 UTC

Market Talk

AstraZeneca Looks Well on Track to Reach 2030 Revenue Target -- Market Talk

7. Juni 2024, 11:55 UTC

Top News

Germany's Merck Bets on AI Drug-Design Partnerships, Rules Out Acquisitions - Interview

5. Juni 2024, 06:00 UTC

Akquisitionen, Fusionen, Übernahmen

AstraZeneca PLC Acquisition of Fusion completed

5. Juni 2024, 06:00 UTC

Akquisitionen, Fusionen, Übernahmen

AstraZeneca PLC Acquisition of Fusion completed

5. Juni 2024, 04:45 UTC

Akquisitionen, Fusionen, Übernahmen

AstraZeneca Announced Acquisition on March 19

5. Juni 2024, 04:43 UTC

Akquisitionen, Fusionen, Übernahmen

AstraZeneca Completes Acquisition of Fusion Pharmaceuticals

31. Mai 2024, 20:08 UTC

Akquisitionen, Fusionen, Übernahmen

Fusion Pharmaceuticals Shareholders to Get Deferred Payment in Form of Contingent Value Right of $3/Shr if Milestone Is Achieved >FUSN

31. Mai 2024, 20:07 UTC

Akquisitionen, Fusionen, Übernahmen

Fusion Pharmaceuticals Shareholders to Receive $21/Shr in Cash Upfront on Completion of Deal >FUSN

31. Mai 2024, 20:06 UTC

Akquisitionen, Fusionen, Übernahmen

Fusion Pharmaceuticals Receives Final Court Order Approving AstraZeneca Deal >FUSN

31. Mai 2024, 13:24 UTC

Top News
Akquisitionen, Fusionen, Übernahmen

AstraZeneca CEO Has No Plans to Retire as He Seeks to Nearly Double Sales by 2030 -- Interview

31. Mai 2024, 13:23 UTC

Akquisitionen, Fusionen, Übernahmen

AstraZeneca CEO: Company Doesn't Need Further Mergers and Acquisitions

31. Mai 2024, 13:23 UTC

Akquisitionen, Fusionen, Übernahmen

AstraZeneca CEO: U.S. Inflation Reduction Act Could Hit Top Line By Around $500M

31. Mai 2024, 13:23 UTC

Akquisitionen, Fusionen, Übernahmen

AstraZeneca's CEO Pascal Soriot Says He Has No Plans to Retire

21. Mai 2024, 07:30 UTC

Market Talk

AstraZeneca's Revenue Target Signals Pipeline Momentum -- Market Talk

21. Mai 2024, 06:17 UTC

Top News

AstraZeneca Targets $80B Revenue by 2030 Through Pipeline Expansion

25. Apr. 2024, 16:43 UTC

Ergebnisse

AstraZeneca, Anglo American, Deutsche Bank: European Stocks in Focus -- WSJ

25. Apr. 2024, 15:28 UTC

Ergebnisse

AstraZeneca, Anglo American, Deutsche Bank: European Stocks in Limelight -- WSJ

25. Apr. 2024, 11:31 UTC

Ergebnisse

AstraZeneca, Sanofi Jump On First-Quarter Earnings; Bristol Myers Lags -- IBD

Peer-Vergleich

Kursveränderung

AstraZeneca PLC ADR Prognose

Kursziel

By TipRanks

7.39% Vorteil

12-Monats-Prognose

Durchschnitt 83.83 USD  7.39%

Hoch 97 USD

Tief 74 USD

Basierend auf 8 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für AstraZeneca PLC ADR – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

8 ratings

7

Buy

1

Halten

0

Sell

Technischer Score

By Trading Central

77.86 / 79.79Unterstützung & Widerstand

Kurzfristig

Strong Bullish Evidence

Mittelfristig

Neutral Evidence

Langfristig

Weak Bullish Evidence